Global Gastrointestinal Cancer Drugs Market Growth 2020-2025

Publisher Name :
Date: 19-Nov-2020
No. of pages: 138

According to this study, over the next five years the Gastrointestinal Cancer Drugs market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Gastrointestinal Cancer Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Cancer Drugs market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Gastrointestinal Cancer Drugs, covering the supply chain analysis, impact assessment to the Gastrointestinal Cancer Drugs market size growth rate in several scenarios, and the measures to be undertaken by Gastrointestinal Cancer Drugs companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Oncology

- Radiology

- Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Hospitals

- Specialized Cancer Treatment Centers

- Clinics

- Ambulatory Surgical Centers

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Amgen & Amgen Ireland

- Novartis

- Bristol-Myers Squibb Company

- Eli Lilly and Company

- Johnson & Johnson Private

- Roche

- Pfizer

- GlaxoSmithKline

- Sanofi

- Celgene Corporation

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Gastrointestinal Cancer Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Gastrointestinal Cancer Drugs market by identifying its various subsegments.

- Focuses on the key global Gastrointestinal Cancer Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Gastrointestinal Cancer Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Gastrointestinal Cancer Drugs submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Gastrointestinal Cancer Drugs Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gastrointestinal Cancer Drugs Consumption 2015-2025
2.1.2 Gastrointestinal Cancer Drugs Consumption CAGR by Region
2.2 Gastrointestinal Cancer Drugs Segment by Type
2.2.1 Oncology
2.2.2 Radiology
2.2.3 Others
2.3 Gastrointestinal Cancer Drugs Consumption by Type
2.3.1 Global Gastrointestinal Cancer Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global Gastrointestinal Cancer Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global Gastrointestinal Cancer Drugs Sale Price by Type (2015-2020)
2.4 Gastrointestinal Cancer Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Specialized Cancer Treatment Centers
2.4.3 Clinics
2.4.4 Ambulatory Surgical Centers
2.5 Gastrointestinal Cancer Drugs Consumption by Application
2.5.1 Global Gastrointestinal Cancer Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global Gastrointestinal Cancer Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global Gastrointestinal Cancer Drugs Sale Price by Type (2015-2020)

3 Global Gastrointestinal Cancer Drugs by Company
3.1 Global Gastrointestinal Cancer Drugs Sales Market Share by Company
3.1.1 Global Gastrointestinal Cancer Drugs Sales by Company (2018-2020)
3.1.2 Global Gastrointestinal Cancer Drugs Sales Market Share by Company (2018-2020)
3.2 Global Gastrointestinal Cancer Drugs Revenue Market Share by Company
3.2.1 Global Gastrointestinal Cancer Drugs Revenue by Company (2018-2020)
3.2.2 Global Gastrointestinal Cancer Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Gastrointestinal Cancer Drugs Sale Price by Company
3.4 Global Gastrointestinal Cancer Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Gastrointestinal Cancer Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Gastrointestinal Cancer Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Gastrointestinal Cancer Drugs by Regions
4.1 Gastrointestinal Cancer Drugs by Regions
4.2 Americas Gastrointestinal Cancer Drugs Consumption Growth
4.3 APAC Gastrointestinal Cancer Drugs Consumption Growth
4.4 Europe Gastrointestinal Cancer Drugs Consumption Growth
4.5 Middle East & Africa Gastrointestinal Cancer Drugs Consumption Growth

5 Americas
5.1 Americas Gastrointestinal Cancer Drugs Consumption by Countries
5.1.1 Americas Gastrointestinal Cancer Drugs Consumption by Countries (2015-2020)
5.1.2 Americas Gastrointestinal Cancer Drugs Value by Countries (2015-2020)
5.2 Americas Gastrointestinal Cancer Drugs Consumption by Type
5.3 Americas Gastrointestinal Cancer Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Gastrointestinal Cancer Drugs Consumption by Regions
6.1.1 APAC Gastrointestinal Cancer Drugs Consumption by Regions (2015-2020)
6.1.2 APAC Gastrointestinal Cancer Drugs Value by Regions (2015-2020)
6.2 APAC Gastrointestinal Cancer Drugs Consumption by Type
6.3 APAC Gastrointestinal Cancer Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Gastrointestinal Cancer Drugs by Countries
7.1.1 Europe Gastrointestinal Cancer Drugs Consumption by Countries (2015-2020)
7.1.2 Europe Gastrointestinal Cancer Drugs Value by Countries (2015-2020)
7.2 Europe Gastrointestinal Cancer Drugs Consumption by Type
7.3 Europe Gastrointestinal Cancer Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Gastrointestinal Cancer Drugs by Countries
8.1.1 Middle East & Africa Gastrointestinal Cancer Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Gastrointestinal Cancer Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Gastrointestinal Cancer Drugs Consumption by Type
8.3 Middle East & Africa Gastrointestinal Cancer Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Gastrointestinal Cancer Drugs Distributors
10.3 Gastrointestinal Cancer Drugs Customer

11 Global Gastrointestinal Cancer Drugs Market Forecast
11.1 Global Gastrointestinal Cancer Drugs Consumption Forecast (2021-2025)
11.2 Global Gastrointestinal Cancer Drugs Forecast by Regions
11.2.1 Global Gastrointestinal Cancer Drugs Forecast by Regions (2021-2025)
11.2.2 Global Gastrointestinal Cancer Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Gastrointestinal Cancer Drugs Forecast by Type
11.8 Global Gastrointestinal Cancer Drugs Forecast by Application

12 Key Players Analysis
12.1 Amgen & Amgen Ireland
12.1.1 Company Information
12.1.2 Gastrointestinal Cancer Drugs Product Offered
12.1.3 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Amgen & Amgen Ireland Latest Developments
12.2 Novartis
12.2.1 Company Information
12.2.2 Gastrointestinal Cancer Drugs Product Offered
12.2.3 Novartis Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Novartis Latest Developments
12.3 Bristol-Myers Squibb Company
12.3.1 Company Information
12.3.2 Gastrointestinal Cancer Drugs Product Offered
12.3.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Bristol-Myers Squibb Company Latest Developments
12.4 Eli Lilly and Company
12.4.1 Company Information
12.4.2 Gastrointestinal Cancer Drugs Product Offered
12.4.3 Eli Lilly and Company Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Eli Lilly and Company Latest Developments
12.5 Johnson & Johnson Private
12.5.1 Company Information
12.5.2 Gastrointestinal Cancer Drugs Product Offered
12.5.3 Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Johnson & Johnson Private Latest Developments
12.6 Roche
12.6.1 Company Information
12.6.2 Gastrointestinal Cancer Drugs Product Offered
12.6.3 Roche Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Roche Latest Developments
12.7 Pfizer
12.7.1 Company Information
12.7.2 Gastrointestinal Cancer Drugs Product Offered
12.7.3 Pfizer Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Pfizer Latest Developments
12.8 GlaxoSmithKline
12.8.1 Company Information
12.8.2 Gastrointestinal Cancer Drugs Product Offered
12.8.3 GlaxoSmithKline Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 GlaxoSmithKline Latest Developments
12.9 Sanofi
12.9.1 Company Information
12.9.2 Gastrointestinal Cancer Drugs Product Offered
12.9.3 Sanofi Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Sanofi Latest Developments
12.10 Celgene Corporation
12.10.1 Company Information
12.10.2 Gastrointestinal Cancer Drugs Product Offered
12.10.3 Celgene Corporation Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Celgene Corporation Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Gastrointestinal Cancer Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Oncology
Table 5. Major Players of Radiology
Table 6. Major Players of Others
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Gastrointestinal Cancer Drugs Consumption Market Share by Type (2015-2020)
Table 9. Global Gastrointestinal Cancer Drugs Revenue by Type (2015-2020) ($ million)
Table 10. Global Gastrointestinal Cancer Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Gastrointestinal Cancer Drugs Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Gastrointestinal Cancer Drugs Consumption Market Share by Application (2015-2020)
Table 14. Global Gastrointestinal Cancer Drugs Value by Application (2015-2020)
Table 15. Global Gastrointestinal Cancer Drugs Value Market Share by Application (2015-2020)
Table 16. Global Gastrointestinal Cancer Drugs Sale Price by Application (2015-2020)
Table 17. Global Gastrointestinal Cancer Drugs Sales by Company (2017-2019) (K Units)
Table 18. Global Gastrointestinal Cancer Drugs Sales Market Share by Company (2017-2019)
Table 19. Global Gastrointestinal Cancer Drugs Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Gastrointestinal Cancer Drugs Revenue Market Share by Company (2017-2019)
Table 21. Global Gastrointestinal Cancer Drugs Sale Price by Company (2017-2019)
Table 22. Global Gastrointestinal Cancer Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Gastrointestinal Cancer Drugs Products Offered
Table 24. Gastrointestinal Cancer Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Gastrointestinal Cancer Drugs Consumption by Regions 2015-2020 (K Units)
Table 26. Global Gastrointestinal Cancer Drugs Consumption Market Share by Regions 2015-2020
Table 27. Global Gastrointestinal Cancer Drugs Value by Regions 2015-2020 ($ Millions)
Table 28. Global Gastrointestinal Cancer Drugs Value Market Share by Regions 2015-2020
Table 29. Americas Gastrointestinal Cancer Drugs Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Gastrointestinal Cancer Drugs Consumption Market Share by Countries (2015-2020)
Table 31. Americas Gastrointestinal Cancer Drugs Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Gastrointestinal Cancer Drugs Value Market Share by Countries (2015-2020)
Table 33. Americas Gastrointestinal Cancer Drugs Consumption by Type (2015-2020) (K Units)
Table 34. Americas Gastrointestinal Cancer Drugs Consumption Market Share by Type (2015-2020)
Table 35. Americas Gastrointestinal Cancer Drugs Consumption by Application (2015-2020) (K Units)
Table 36. Americas Gastrointestinal Cancer Drugs Consumption Market Share by Application (2015-2020)
Table 37. APAC Gastrointestinal Cancer Drugs Consumption by Regions (2015-2020) (K Units)
Table 38. APAC Gastrointestinal Cancer Drugs Consumption Market Share by Regions (2015-2020)
Table 39. APAC Gastrointestinal Cancer Drugs Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Gastrointestinal Cancer Drugs Value Market Share by Regions (2015-2020)
Table 41. APAC Gastrointestinal Cancer Drugs Consumption by Type (2015-2020) (K Units)
Table 42. APAC Gastrointestinal Cancer Drugs Consumption Market Share by Type (2015-2020)
Table 43. APAC Gastrointestinal Cancer Drugs Consumption by Application (2015-2020) (K Units)
Table 44. APAC Gastrointestinal Cancer Drugs Consumption Market Share by Application (2015-2020)
Table 45. Europe Gastrointestinal Cancer Drugs Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Gastrointestinal Cancer Drugs Consumption Market Share by Countries (2015-2020)
Table 47. Europe Gastrointestinal Cancer Drugs Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Gastrointestinal Cancer Drugs Value Market Share by Countries (2015-2020)
Table 49. Europe Gastrointestinal Cancer Drugs Consumption by Type (2015-2020) (K Units)
Table 50. Europe Gastrointestinal Cancer Drugs Consumption Market Share by Type (2015-2020)
Table 51. Europe Gastrointestinal Cancer Drugs Consumption by Application (2015-2020) (K Units)
Table 52. Europe Gastrointestinal Cancer Drugs Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Gastrointestinal Cancer Drugs Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Gastrointestinal Cancer Drugs Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Gastrointestinal Cancer Drugs Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Gastrointestinal Cancer Drugs Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Gastrointestinal Cancer Drugs Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Gastrointestinal Cancer Drugs Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Gastrointestinal Cancer Drugs Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Gastrointestinal Cancer Drugs Consumption Market Share by Application (2015-2020)
Table 61. Gastrointestinal Cancer Drugs Distributors List
Table 62. Gastrointestinal Cancer Drugs Customer List
Table 63. Global Gastrointestinal Cancer Drugs Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Gastrointestinal Cancer Drugs Consumption Market Forecast by Regions
Table 65. Global Gastrointestinal Cancer Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Gastrointestinal Cancer Drugs Value Market Share Forecast by Regions
Table 67. Global Gastrointestinal Cancer Drugs Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Gastrointestinal Cancer Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Gastrointestinal Cancer Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Gastrointestinal Cancer Drugs Value Market Share Forecast by Type (2021-2025)
Table 71. Global Gastrointestinal Cancer Drugs Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Gastrointestinal Cancer Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Gastrointestinal Cancer Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Gastrointestinal Cancer Drugs Value Market Share Forecast by Application (2021-2025)
Table 75. Amgen & Amgen Ireland Product Offered
Table 76. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 77. Amgen & Amgen Ireland Main Business
Table 78. Amgen & Amgen Ireland Latest Developments
Table 79. Amgen & Amgen Ireland Basic Information, Company Total Revenue (in $ million), Gastrointestinal Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis Product Offered
Table 81. Novartis Gastrointestinal Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments
Table 84. Novartis Basic Information, Company Total Revenue (in $ million), Gastrointestinal Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Bristol-Myers Squibb Company Product Offered
Table 86. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 87. Bristol-Myers Squibb Company Main Business
Table 88. Bristol-Myers Squibb Company Latest Developments
Table 89. Bristol-Myers Squibb Company Basic Information, Company Total Revenue (in $ million), Gastrointestinal Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Eli Lilly and Company Product Offered
Table 91. Eli Lilly and Company Gastrointestinal Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 92. Eli Lilly and Company Main Business
Table 93. Eli Lilly and Company Latest Developments
Table 94. Eli Lilly and Company Basic Information, Company Total Revenue (in $ million), Gastrointestinal Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Johnson & Johnson Private Product Offered
Table 96. Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 97. Johnson & Johnson Private Main Business
Table 98. Johnson & Johnson Private Latest Developments
Table 99. Johnson & Johnson Private Basic Information, Company Total Revenue (in $ million), Gastrointestinal Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Roche Product Offered
Table 101. Roche Gastrointestinal Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 102. Roche Main Business
Table 103. Roche Latest Developments
Table 104. Roche Basic Information, Company Total Revenue (in $ million), Gastrointestinal Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Pfizer Product Offered
Table 106. Pfizer Basic Information, Company Total Revenue (in $ million), Gastrointestinal Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Pfizer Main Business
Table 108. Pfizer Latest Developments
Table 109. Pfizer Gastrointestinal Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 110. GlaxoSmithKline Product Offered
Table 111. GlaxoSmithKline Gastrointestinal Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 112. GlaxoSmithKline Main Business
Table 113. GlaxoSmithKline Latest Developments
Table 114. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), Gastrointestinal Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Sanofi Product Offered
Table 116. Sanofi Gastrointestinal Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 117. Sanofi Main Business
Table 118. Sanofi Latest Developments
Table 119. Sanofi Basic Information, Company Total Revenue (in $ million), Gastrointestinal Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Celgene Corporation Product Offered
Table 121. Celgene Corporation Gastrointestinal Cancer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 122. Celgene Corporation Main Business
Table 123. Celgene Corporation Latest Developments
Table 124. Celgene Corporation Basic Information, Company Total Revenue (in $ million), Gastrointestinal Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Gastrointestinal Cancer Drugs
Figure 2. Gastrointestinal Cancer Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Gastrointestinal Cancer Drugs Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Gastrointestinal Cancer Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Oncology
Figure 7. Product Picture of Radiology
Figure 8. Product Picture of Others
Figure 9. Global Gastrointestinal Cancer Drugs Consumption Market Share by Type (2015-2020)
Figure 10. Global Gastrointestinal Cancer Drugs Value Market Share by Type (2015-2020)
Figure 11. Gastrointestinal Cancer Drugs Consumed in Hospitals
Figure 12. Global Gastrointestinal Cancer Drugs Market: Hospitals (2015-2020) (K Units)
Figure 13. Global Gastrointestinal Cancer Drugs Market: Hospitals (2015-2020) ($ Millions)
Figure 14. Gastrointestinal Cancer Drugs Consumed in Specialized Cancer Treatment Centers
Figure 15. Global Gastrointestinal Cancer Drugs Market: Specialized Cancer Treatment Centers (2015-2020) (K Units)
Figure 16. Global Gastrointestinal Cancer Drugs Market: Specialized Cancer Treatment Centers (2015-2020) ($ Millions)
Figure 17. Gastrointestinal Cancer Drugs Consumed in Clinics
Figure 18. Global Gastrointestinal Cancer Drugs Market: Clinics (2015-2020) (K Units)
Figure 19. Global Gastrointestinal Cancer Drugs Market: Clinics (2015-2020) ($ Millions)
Figure 20. Gastrointestinal Cancer Drugs Consumed in Ambulatory Surgical Centers
Figure 21. Global Gastrointestinal Cancer Drugs Market: Ambulatory Surgical Centers (2015-2020) (K Units)
Figure 22. Global Gastrointestinal Cancer Drugs Market: Ambulatory Surgical Centers (2015-2020) ($ Millions)
Figure 23. Global Gastrointestinal Cancer Drugs Consumption Market Share by Application (2015-2020)
Figure 24. Global Gastrointestinal Cancer Drugs Value Market Share by Application (2015-2020)
Figure 25. Global Gastrointestinal Cancer Drugs Sales Market Share by Company in 2017
Figure 26. Global Gastrointestinal Cancer Drugs Sales Market Share by Company in 2019
Figure 27. Global Gastrointestinal Cancer Drugs Revenue Market Share by Company in 2017
Figure 28. Global Gastrointestinal Cancer Drugs Revenue Market Share by Company in 2019
Figure 29. Global Gastrointestinal Cancer Drugs Sale Price by Company in 2019
Figure 30. Global Gastrointestinal Cancer Drugs Consumption Market Share by Regions 2015-2020
Figure 31. Global Gastrointestinal Cancer Drugs Value Market Share by Regions 2015-2020
Figure 32. Americas Gastrointestinal Cancer Drugs Consumption 2015-2020 (K Units)
Figure 33. Americas Gastrointestinal Cancer Drugs Value 2015-2020 ($ Millions)
Figure 34. APAC Gastrointestinal Cancer Drugs Consumption 2015-2020 (K Units)
Figure 35. APAC Gastrointestinal Cancer Drugs Value 2015-2020 ($ Millions)
Figure 36. Europe Gastrointestinal Cancer Drugs Consumption 2015-2020 (K Units)
Figure 37. Europe Gastrointestinal Cancer Drugs Value 2015-2020 ($ Millions)
Figure 38. Middle East & Africa Gastrointestinal Cancer Drugs Consumption 2015-2020 (K Units)
Figure 39. Middle East & Africa Gastrointestinal Cancer Drugs Value 2015-2020 ($ Millions)
Figure 40. Americas Gastrointestinal Cancer Drugs Consumption Market Share by Countries in 2019
Figure 41. Americas Gastrointestinal Cancer Drugs Value Market Share by Countries in 2019
Figure 42. Americas Gastrointestinal Cancer Drugs Consumption Market Share by Type in 2019
Figure 43. Americas Gastrointestinal Cancer Drugs Consumption Market Share by Application in 2019
Figure 44. United States Gastrointestinal Cancer Drugs Consumption Growth 2015-2020 (K Units)
Figure 45. United States Gastrointestinal Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 46. Canada Gastrointestinal Cancer Drugs Consumption Growth 2015-2020 (K Units)
Figure 47. Canada Gastrointestinal Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 48. Mexico Gastrointestinal Cancer Drugs Consumption Growth 2015-2020 (K Units)
Figure 49. Mexico Gastrointestinal Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 50. APAC Gastrointestinal Cancer Drugs Consumption Market Share by Countries in 2019
Figure 51. APAC Gastrointestinal Cancer Drugs Value Market Share by Regions in 2019
Figure 52. APAC Gastrointestinal Cancer Drugs Consumption Market Share by Type in 2019
Figure 53. APAC Gastrointestinal Cancer Drugs Consumption Market Share by Application in 2019
Figure 54. China Gastrointestinal Cancer Drugs Consumption Growth 2015-2020 (K Units)
Figure 55. China Gastrointestinal Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 56. Japan Gastrointestinal Cancer Drugs Consumption Growth 2015-2020 (K Units)
Figure 57. Japan Gastrointestinal Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 58. Korea Gastrointestinal Cancer Drugs Consumption Growth 2015-2020 (K Units)
Figure 59. Korea Gastrointestinal Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 60. Southeast Asia Gastrointestinal Cancer Drugs Consumption Growth 2015-2020 (K Units)
Figure 61. Southeast Asia Gastrointestinal Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 62. India Gastrointestinal Cancer Drugs Consumption Growth 2015-2020 (K Units)
Figure 63. India Gastrointestinal Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 64. Australia Gastrointestinal Cancer Drugs Consumption Growth 2015-2020 (K Units)
Figure 65. Australia Gastrointestinal Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 66. Europe Gastrointestinal Cancer Drugs Consumption Market Share by Countries in 2019
Figure 67. Europe Gastrointestinal Cancer Drugs Value Market Share by Countries in 2019
Figure 68. Europe Gastrointestinal Cancer Drugs Consumption Market Share by Type in 2019
Figure 69. Europe Gastrointestinal Cancer Drugs Consumption Market Share by Application in 2019
Figure 70. Germany Gastrointestinal Cancer Drugs Consumption Growth 2015-2020 (K Units)
Figure 71. Germany Gastrointestinal Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 72. France Gastrointestinal Cancer Drugs Consumption Growth 2015-2020 (K Units)
Figure 73. France Gastrointestinal Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 74. UK Gastrointestinal Cancer Drugs Consumption Growth 2015-2020 (K Units)
Figure 75. UK Gastrointestinal Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 76. Italy Gastrointestinal Cancer Drugs Consumption Growth 2015-2020 (K Units)
Figure 77. Italy Gastrointestinal Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 78. Russia Gastrointestinal Cancer Drugs Consumption Growth 2015-2020 (K Units)
Figure 79. Russia Gastrointestinal Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 80. Middle East & Africa Gastrointestinal Cancer Drugs Consumption Market Share by Countries in 2019
Figure 81. Middle East & Africa Gastrointestinal Cancer Drugs Value Market Share by Countries in 2019
Figure 82. Middle East & Africa Gastrointestinal Cancer Drugs Consumption Market Share by Type in 2019
Figure 83. Middle East & Africa Gastrointestinal Cancer Drugs Consumption Market Share by Application in 2019
Figure 84. Egypt Gastrointestinal Cancer Drugs Consumption Growth 2015-2020 (K Units)
Figure 85. Egypt Gastrointestinal Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 86. South Africa Gastrointestinal Cancer Drugs Consumption Growth 2015-2020 (K Units)
Figure 87. South Africa Gastrointestinal Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 88. Israel Gastrointestinal Cancer Drugs Consumption Growth 2015-2020 (K Units)
Figure 89. Israel Gastrointestinal Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 90. Turkey Gastrointestinal Cancer Drugs Consumption Growth 2015-2020 (K Units)
Figure 91. Turkey Gastrointestinal Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 92. GCC Countries Gastrointestinal Cancer Drugs Consumption Growth 2015-2020 (K Units)
Figure 93. GCC Countries Gastrointestinal Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 94. Global Gastrointestinal Cancer Drugs Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 95. Global Gastrointestinal Cancer Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 96. Americas Gastrointestinal Cancer Drugs Consumption 2021-2025 (K Units)
Figure 97. Americas Gastrointestinal Cancer Drugs Value 2021-2025 ($ Millions)
Figure 98. APAC Gastrointestinal Cancer Drugs Consumption 2021-2025 (K Units)
Figure 99. APAC Gastrointestinal Cancer Drugs Value 2021-2025 ($ Millions)
Figure 100. Europe Gastrointestinal Cancer Drugs Consumption 2021-2025 (K Units)
Figure 101. Europe Gastrointestinal Cancer Drugs Value 2021-2025 ($ Millions)
Figure 102. Middle East & Africa Gastrointestinal Cancer Drugs Consumption 2021-2025 (K Units)
Figure 103. Middle East & Africa Gastrointestinal Cancer Drugs Value 2021-2025 ($ Millions)
Figure 104. United States Gastrointestinal Cancer Drugs Consumption 2021-2025 (K Units)
Figure 105. United States Gastrointestinal Cancer Drugs Value 2021-2025 ($ Millions)
Figure 106. Canada Gastrointestinal Cancer Drugs Consumption 2021-2025 (K Units)
Figure 107. Canada Gastrointestinal Cancer Drugs Value 2021-2025 ($ Millions)
Figure 108. Mexico Gastrointestinal Cancer Drugs Consumption 2021-2025 (K Units)
Figure 109. Mexico Gastrointestinal Cancer Drugs Value 2021-2025 ($ Millions)
Figure 110. Brazil Gastrointestinal Cancer Drugs Consumption 2021-2025 (K Units)
Figure 111. Brazil Gastrointestinal Cancer Drugs Value 2021-2025 ($ Millions)
Figure 112. China Gastrointestinal Cancer Drugs Consumption 2021-2025 (K Units)
Figure 113. China Gastrointestinal Cancer Drugs Value 2021-2025 ($ Millions)
Figure 114. Japan Gastrointestinal Cancer Drugs Consumption 2021-2025 (K Units)
Figure 115. Japan Gastrointestinal Cancer Drugs Value 2021-2025 ($ Millions)
Figure 116. Korea Gastrointestinal Cancer Drugs Consumption 2021-2025 (K Units)
Figure 117. Korea Gastrointestinal Cancer Drugs Value 2021-2025 ($ Millions)
Figure 118. Southeast Asia Gast
  • Global Knee Replacement Implants Market Growth 2020-2025
    Published: 25-Nov-2020        Price: US 3660 Onwards        Pages: 167
    According to this study, over the next five years the Knee Replacement Implants market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Knee Replacement Implants business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Knee Replacement Impl......
  • Global Medical Nutrition Market Growth (Status and Outlook) 2020-2025
    Published: 25-Nov-2020        Price: US 3660 Onwards        Pages: 117
    According to this study, over the next five years the Medical Nutrition market will register a 4.6%% CAGR in terms of revenue, the global market size will reach $ 39060 million by 2025, from $ 32650 million in 2019. In particular, this report presents the global revenue market share of key companies in Medical Nutrition business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Medical Nutrition market by product type,......
  • Global Cardiac Biomarker Market Growth 2020-2025
    Published: 25-Nov-2020        Price: US 3660 Onwards        Pages: 137
    According to this study, over the next five years the Cardiac Biomarker market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cardiac Biomarker business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Cardiac Biomarker market by product t......
  • Global Peony Root-Bark Extract Market Growth 2020-2025
    Published: 24-Nov-2020        Price: US 3660 Onwards        Pages: 159
    According to this study, over the next five years the Peony Root-Bark Extract market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Peony Root-Bark Extract business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Peony Root-Bark Extract m......
  • Global Pigskin Gelatin Market Growth 2020-2025
    Published: 24-Nov-2020        Price: US 3660 Onwards        Pages: 167
    According to this study, over the next five years the Pigskin Gelatin market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pigskin Gelatin business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Pigskin Gelatin market by product type, a......
  • Global Fluff Sponges Market Growth 2020-2025
    Published: 24-Nov-2020        Price: US 3660 Onwards        Pages: 158
    According to this study, over the next five years the Fluff Sponges market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Fluff Sponges business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Fluff Sponges market by product type, applica......
  • Global Sterile X-Ray Detectable Lap Sponges Market Growth 2020-2025
    Published: 24-Nov-2020        Price: US 3660 Onwards        Pages: 166
    According to this study, over the next five years the Sterile X-Ray Detectable Lap Sponges market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Sterile X-Ray Detectable Lap Sponges business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of......
  • Muscarinic Acetylcholine Receptor M1 Antagonists - Pipeline Insight, 2020
    Published: 24-Nov-2020        Price: US 2000 Onwards        Pages: 70
    DelveInsight's, "Muscarinic Acetylcholine Receptor M1 Antagonists- Pipeline Insight, 2020," report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Muscarinic Acetylcholine Receptor M1 Antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products i......
  • PARP Inhibitors - Pipeline Insight, 2020
    Published: 24-Nov-2020        Price: US 2500 Onwards        Pages: 80
    DelveInsight's, "PARP Inhibitors- Pipeline Insight, 2020," report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in PARP Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered - Global cov......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs